8 April 2020
COVID-19 Vaccine & Therapy Research Boosted by Six New Projects in Rapid Response
Six new studies into the novel coronavirus have been funded by the UK government, including testing a vaccine, developing therapies...
31 March 2020
Q&A: Cell and Gene Processing Moves Forward through ‘Experiential Learning’
Colin MacKay, CEO of Symbiosis Pharmaceutical Services, recently took part in a Q&A interview with BioPharma-Reporter, discussing how increased manufacturing...
13 May 2019
Freeline, Symbiosis and the Cell and Gene Therapy Catapult Secure Collaborative Funding from Innovate UK
London, UK – Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, has secured a...
24 September 2018
Symbiosis Secures FDA Viral Vector Process Approval
Stirling, UK – SYMBIOSIS Pharmaceutical Services, a fast-growing specialist sterile manufacturing CDMO, has reported FDA approval for its viral vector...
1 February 2018
Cobra Biologics and Symbiosis Awarded £1.9M ($2.5M USD) Innovate UK Grant
Keele and Stirling, UK, 1 February 2018: Cobra Biologics (Cobra), an international contract development and manufacturing organisation (CDMO) of biologics...
13 February 2017
Scottish CMO Opens US Office
Symbiosis Pharmaceutical Services is set to open an office in North America in response to continued demand from US-based biotechnology...
21 May 2015
CMO in Bulk Lyophilisation Launch
Stirling, UK – STERILE manufacturing specialist Symbiosis Pharmaceutical Services has unveiled a new bulk lyophilisation (freeze drying) service after winning...
17 December 2014
Symbiosis Boosts US Presence in Response to Market Growth
UK-based sterile filling specialist Symbiosis Pharmaceutical Services has strengthened its North American footprint with the appointment of a US-based business...
5 July 2013
Symbiosis Completes Full Cleanroom Qualification
Symbiosis successfully completes the full qualification of its two sterile fill/finish and lyophilisation cleanroom suites. Symbiosis is delighted to announce...
1 February 2013
Another Successful Regulatory Milestone Achieved
Leading on from the receipt of our Investigational Medicinal Products (IMP-MA) manufacturing licence from the UK Government regulator, the MHRA,...
1 October 2012
Symbiosis Launches Multi-million Pound Sterile Drug Manufacturing Capability in Scotland
Symbiosis Pharmaceutical Services Limited, an MHRA-approved sterile manufacturing facility based in Stirling, Scotland is an exciting, young company specializing in...